Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Lysteda (tranexamic acid) Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2011

Summary View

 

5 WARNINGS AND PRECAUTIONS

5.1 thromboembolic Risk
  • ...Concomittant Use of Hormonal Contraceptives...
5.4 Ligneous Conjunctivitis
  • section added
-
-